本页面由Tiger Trade Technology Pte. Ltd.提供服务

Caris Life Sciences, Inc.

18.75
-0.2600-1.37%
盘前19.500.7500+4.00%05:22 EDT
成交量:150.90万
成交额:2,802.40万
市值:52.90亿
市盈率:-5.83
高:18.89
开:18.87
低:18.23
收:19.01
52周最高:42.50
52周最低:16.28
股本:2.82亿
流通股本:9,191.75万
量比:0.69
换手率:1.64%
股息:- -
股息率:- -
每股收益(TTM):-3.2173
每股收益(LYR):-3.2200
净资产收益率:-45.37%
总资产收益率:3.84%
市净率:9.16
市盈率(LYR):-5.82

数据加载中...

2021/06/08

重要事件披露

8-K - Current report
2021/05/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/30

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/29

重要事件披露

8-K - Current report
2021/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/31

重要事件披露

8-K - Current report
2020/12/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/30

重要事件披露

8-K - Current report
2020/11/06

重要事件披露

8-K - Current report
2020/11/02

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]